文献速递肾小球疾病

Kindlin-2与Rho GDP解离抑制因子α结合抑制Rac1激活及足细胞损伤

Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.
PubMed 文献 · J Am Soc Nephrol · 2017-08-03

该研究在体内探究Kindlin-2在足细胞行为中的作用。足细胞特异性敲除Kindlin-2导致肌动蛋白骨架改变、裂孔膜蛋白减少、足突消失,最终大量蛋白尿和肾衰竭死亡。机制上,Kindlin-2缺失降低RhoGDIα表达,使Rac1从RhoGDIα解离并过度激活,增加足细胞运动性;抑制Rac1激活可减轻足细胞缺陷和蛋白尿。

要点

  • 足细胞Kindlin-2缺失导致足突消失、裂孔膜蛋白减少及大量蛋白尿。
  • Kindlin-2通过结合RhoGDIα维持Rac1低活性,缺失则Rac1过度激活。
  • 抑制Rac1激活可减轻Kindlin-2缺失所致的足细胞损伤和蛋白尿。

核心结论

  • Kindlin-2-RhoGDIα-Rac1信号轴对足细胞结构和功能至关重要,可能成为治疗足细胞损伤和肾小球疾病的靶点。

研究设计与样本

  • 体内小鼠模型研究:足细胞特异性敲除Kindlin-2,结合蛋白质组学分析和体外免疫共沉淀实验。

主要发现

  • 足细胞敲除Kindlin-2引起肌动蛋白骨架改变、裂孔膜蛋白水平降低、足突消失,最终大量蛋白尿和肾衰竭死亡。
  • Kindlin-2缺失显著降低RhoGDIα表达,导致Rac1与RhoGDIα解离,Rac1过度激活和足细胞运动性增加。
  • 抑制Rac1激活可有效抑制足细胞运动性,并减轻Kindlin-2缺失诱导的足细胞缺陷和蛋白尿。

临床怎么用

  • 提示Rac1过度激活参与足细胞损伤,抑制Rac1可能作为足细胞损伤相关肾小球疾病的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alteration of podocyte behavior is critically involved in the development and progression of many forms of human glomerular diseases. The molecular mechanisms that control podocyte behavior, however, are not well understood. Here, we investigated the role of Kindlin-2, a component of cell-matrix adhesions, in podocyte behavior in vivo Ablation of Kindlin-2 in podocytes resulted in alteration of actin cytoskeletal organization, reduction of the levels of slit diaphragm proteins, effacement of podocyte foot processes, and ultimately massive proteinuria and death due to kidney failure. Through proteomic analyses and in vitro coimmunoprecipitation experiments, we identified Rho GDP-dissociation inhibitor α (RhoGDIα) as a Kindlin-2-associated protein. Loss of Kindlin-2 in podocytes significantly reduced the expression of RhoGDIα and resulted in the dissociation of Rac1 from RhoGDIα, leading to Rac1 hyperactivation and increased motility of podocytes. Inhibition of Rac1 activation effectively suppressed podocyte motility and alleviated the podocyte defects and proteinuria induced by the loss of Kindlin-2 in vivo Our results identify a novel Kindlin-2-RhoGDIα-Rac1 signaling axis that is critical for regulation of podocyte structure and function in vivo and provide evidence that it may serve as a useful target for therapeutic control of podocyte injury and associated glomerular diseases.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sun Y, Guo C, Ma P, et al. Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury. J Am Soc Nephrol. 2017. PMID: 28775002. doi:10.1681/ASN.2016091021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。